Case Report: Cutaneous Leishmaniasis due to Leishmania (Viannia) panamensis in Two Travelers Successfully Treated with Miltefosine
- 2 September 2020
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (3) , 1081-1084
Abstract
We present two cases of Leishmania (V) panamensis in returning travelers from Central America successfully treated with miltefosine. The couple presented with ulcerative skin lesions nonresponsive to antibiotics. Skin biopsy with PCR revealed L. (V) panamensis. To prevent the development of mucosal disease and avoid the inconvenience of parental therapy, we treated both patients with oral miltefosine. We suggest that miltefosine represents an important therapeutic alternative in the treatment of cutaneous lesions caused by L. panamensis and in preventing mucosal involvement.Keywords
This publication has 18 references indexed in Scilit:
- The growing challenge of leishmaniasis in travelersTravel Medicine and Infectious Disease, 2014
- Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in ChildrenThe Journal of Infectious Diseases, 2012
- Leishmania RNA virus: when the host pays the tollFrontiers in Cellular and Infection Microbiology, 2012
- Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled TrialPLOS Neglected Tropical Diseases, 2010
- Efficacy of Miltefosine for the Treatment of American Cutaneous LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 2010
- Leishmania tropica–Induced Cutaneous and Presumptive Concomitant Viscerotropic Leishmaniasis With Prolonged IncubationArchives of Dermatology, 2009
- Low Plasma Membrane Expression of the Miltefosine Transport Complex Renders Leishmania braziliensis Refractory to the DrugAntimicrobial Agents and Chemotherapy, 2009
- Miltefosine for New World Cutaneous LeishmaniasisClinical Infectious Diseases, 2004
- Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral AgentClinical Infectious Diseases, 2001
- LeishmaniasisThe Lancet, 1999